Editorial: Risk factors for Rheumatoid Arthritis and pre-Rheumatoid Arthritis

por Sapart, Emillie, Faria, Margarida, Dierckx, Stephanie, Durez, Patrick, Fonseca, João Eurico
Publicado 2022

Anti-TNF Induced Sarcoidosis-Like Disease in Rheumatoid Arthritis Patients: Review Cases from the RA UCLouvain Brussels Cohort

por Theunssens, Xavier, Bricman, Laura, Dierckx, Stéphanie, Sapart, Emilie, Sokolova, Tatiana, Avramovska, Aleksandra, Durez, Patrick
Publicado 2022

Should We Use bDMARDs as an Induction Therapy in Early and Severe Rheumatoid Arthritis? Results at 5 years from the ERA UCLouvain Brussels Cohort

por Sapart, Emilie, Sokolova, Tatiana, de Montjoye, Stéphanie, Dierckx, Stéphanie, Nzeusseu, Adrien, Avramovska, Aleksandra, Meric de Bellefon, Laurent, Durez, Patrick
Publicado 2023

Tapering of biological antirheumatic drugs in rheumatoid arthritis patients is achievable and cost-effective in daily clinical practice: data from the Brussels UCLouvain RA Cohort

por Dierckx, Stéphanie, Sokolova, Tatiana, Lauwerys, Bernard R., Avramovska, Aleksandra, de Bellefon, Laurent Meric, Toukap, Adrien Nzeusseu, Stoenoiu, Maria, Houssiau, Frédéric A., Durez, Patrick
Publicado 2020